相关实验视频
Updated: Jul 22, 2026

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Published on: March 6, 2012
大脑质瘤的个性化医学:向治疗,患者衍生瘤模型 (评论)
K S Yashin1, D V Yuzhakova2, D A Sachkova3
1Neurosurgeon, Department of Neurosurgery, University Clinic; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia; Assistant, Department of Traumatology and Neurosurgery named after M.V. Kolokoltsev; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia; Oncologist, Polyclinic Department; Nizhny Novgorod Regional Oncologic Dispensary, 11/1 Delovaya St., Nizhny Novgorod, 603126, Russia.
个性化向疗法可以提高脑质瘤治疗的疗效. 患者衍生瘤模型有助于为这些具有挑战性的脑瘤选择最佳的药物疗法.
科学领域:
- 神经瘤学神经瘤学
- 癌症治疗方法 癌症治疗方法
- 基因组学就是基因组学.
背景情况:
- 质瘤是最常见的原发性恶性脑瘤.
- 传统的质瘤治疗方法在历史上产生了不令人满意的结果.
- 最近的进展包括个性化的向疗法和患者衍生瘤模型.
研究的目的:
- 审查推动质瘤生长的分子和遗传机制.
- 评估个性化方法与质瘤标准疗法的疗效.
- 突出患者衍生瘤模型在预测药物有效性的作用.
主要方法:
- 对质瘤中的分子和遗传机制的文献综述.
- 对癌症治疗的个性化向疗法的分析.
- 检查患者衍生瘤模型用于药物查.
主要成果:
- 个性化向疗法与标准质瘤治疗相比,显示出更高的疗效.
- 来自患者的瘤模型显示出对测试各种抗瘤药物的前景.
- 预测特定药物治疗方案的有效性仍然是一个挑战.
结论:
- 对质瘤治疗的个性化方法显示出卓越的疗效.
- 患者衍生瘤模型对于推进质瘤药物发现和选择至关重要.
- 需要进一步的研究才能充分利用这些模型进行临床应用.
更多相关视频
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
04:01Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
相关概念视频
Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...